Skip to main content
[Preprint]. 2021 Mar 10:2021.02.05.21251182. [Version 2] doi: 10.1101/2021.02.05.21251182

Figure 1. B.1.351 variants show decreased susceptibility to neutralizing monoclonal anibodies.

Figure 1.

The ability of the indicated monoclonal antibodies (mAbs) to neutralize Wuhan-Hu-1, B.1.351 and B.1.351Δ242-243 pseudovirus infectivity in 293T-hACE2 cells was measured as indicated. The epitope specificity of each mAb is shown in parentheses (RBD: receptor binding domain; NTD: N-terminal domain; EBV: Epstein-Barr virus). Data points represent the mean of two techincal replicates. Data is represenative of two independent experiments.